Cargando…
COPD symptom burden: impact on health care resource utilization, and work and activity impairment
BACKGROUND: Chronic obstructive pulmonary disease (COPD) can greatly impact the quality of life by limiting patients’ activities. However, data on impact of symptomatic burden on the health care resource utilization (HCRU) and employment in COPD are lacking. We examined the association between COPD...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327905/ https://www.ncbi.nlm.nih.gov/pubmed/28260874 http://dx.doi.org/10.2147/COPD.S123896 |
_version_ | 1782510818083995648 |
---|---|
author | Ding, Bo Small, Mark Bergström, Gina Holmgren, Ulf |
author_facet | Ding, Bo Small, Mark Bergström, Gina Holmgren, Ulf |
author_sort | Ding, Bo |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) can greatly impact the quality of life by limiting patients’ activities. However, data on impact of symptomatic burden on the health care resource utilization (HCRU) and employment in COPD are lacking. We examined the association between COPD Assessment Test (CAT) score and direct/indirect costs associated with HCRU and work productivity. METHODS: Data from >2,100 patients with COPD consulting for routine care were derived from respiratory disease-specific programs in Europe, the USA and China. Questionnaires, including CAT and Work Productivity and Activity Impairment (WPAI), were used to collect the past and current disease status data and HCRU characteristics from physicians (general practitioners/specialists) and patients. A regression approach was used to quantify the association of CAT with HCRU and WPAI variables. CAT score was modeled as a continuous independent variable (range: 0–40). RESULTS: Ninety percent of patients with COPD had a CAT score ≥10. Short-acting therapy and maintenance bronchodilator monotherapy, respectively, were currently prescribed to patients with CAT scores of 10–19 (5.8% and 27.6%), 20–29 (5.1% and 13.1%) and 30–40 (2.8% and 6.6%). Prescribing of maintenance bronchodilator dual therapy was low across the CAT score groups (0–9, 7.8%; 10–19, 6.4%; 20–29, 5.9%; 30–40, 4.4%), whereas maintenance triple combination therapy was prescribed more commonly in patients with higher CAT scores (0–9, 16.1%; 10–19, 23.2%; 20–29, 25.9%; 30–40, 35.5%). Increasing CAT scores were significantly associated with a higher frequency of primary care physician visits (P<0.001), pulmonologist visits (P=0.007), exacerbations requiring hospitalization (P<0.001) and WPAI scores (P<0.001). CONCLUSION: Most patients with COPD presented with high symptom levels, despite being treated for COPD. Increasing symptom burden was associated with increasing HCRU and had a detrimental impact on work productivity. |
format | Online Article Text |
id | pubmed-5327905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53279052017-03-03 COPD symptom burden: impact on health care resource utilization, and work and activity impairment Ding, Bo Small, Mark Bergström, Gina Holmgren, Ulf Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) can greatly impact the quality of life by limiting patients’ activities. However, data on impact of symptomatic burden on the health care resource utilization (HCRU) and employment in COPD are lacking. We examined the association between COPD Assessment Test (CAT) score and direct/indirect costs associated with HCRU and work productivity. METHODS: Data from >2,100 patients with COPD consulting for routine care were derived from respiratory disease-specific programs in Europe, the USA and China. Questionnaires, including CAT and Work Productivity and Activity Impairment (WPAI), were used to collect the past and current disease status data and HCRU characteristics from physicians (general practitioners/specialists) and patients. A regression approach was used to quantify the association of CAT with HCRU and WPAI variables. CAT score was modeled as a continuous independent variable (range: 0–40). RESULTS: Ninety percent of patients with COPD had a CAT score ≥10. Short-acting therapy and maintenance bronchodilator monotherapy, respectively, were currently prescribed to patients with CAT scores of 10–19 (5.8% and 27.6%), 20–29 (5.1% and 13.1%) and 30–40 (2.8% and 6.6%). Prescribing of maintenance bronchodilator dual therapy was low across the CAT score groups (0–9, 7.8%; 10–19, 6.4%; 20–29, 5.9%; 30–40, 4.4%), whereas maintenance triple combination therapy was prescribed more commonly in patients with higher CAT scores (0–9, 16.1%; 10–19, 23.2%; 20–29, 25.9%; 30–40, 35.5%). Increasing CAT scores were significantly associated with a higher frequency of primary care physician visits (P<0.001), pulmonologist visits (P=0.007), exacerbations requiring hospitalization (P<0.001) and WPAI scores (P<0.001). CONCLUSION: Most patients with COPD presented with high symptom levels, despite being treated for COPD. Increasing symptom burden was associated with increasing HCRU and had a detrimental impact on work productivity. Dove Medical Press 2017-02-21 /pmc/articles/PMC5327905/ /pubmed/28260874 http://dx.doi.org/10.2147/COPD.S123896 Text en © 2017 Ding et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Ding, Bo Small, Mark Bergström, Gina Holmgren, Ulf COPD symptom burden: impact on health care resource utilization, and work and activity impairment |
title | COPD symptom burden: impact on health care resource utilization, and work and activity impairment |
title_full | COPD symptom burden: impact on health care resource utilization, and work and activity impairment |
title_fullStr | COPD symptom burden: impact on health care resource utilization, and work and activity impairment |
title_full_unstemmed | COPD symptom burden: impact on health care resource utilization, and work and activity impairment |
title_short | COPD symptom burden: impact on health care resource utilization, and work and activity impairment |
title_sort | copd symptom burden: impact on health care resource utilization, and work and activity impairment |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327905/ https://www.ncbi.nlm.nih.gov/pubmed/28260874 http://dx.doi.org/10.2147/COPD.S123896 |
work_keys_str_mv | AT dingbo copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment AT smallmark copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment AT bergstromgina copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment AT holmgrenulf copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment |